CAMBRIDGE, Mass., June 06, 2024 -- Anthos Therapeutics, Inc., a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences (BXLS), today provided an update on the transition of...
CAMBRIDGE, Mass., June 06, 2024 -- Anthos Therapeutics, Inc., a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences (BXLS), today provided an update on the transition of...
CAMBRIDGE, Mass., June 06, 2024...